Cargando…

308 Primary Membranous Nephropathy Shortly After COVID-19 Vaccination

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027987/ http://dx.doi.org/10.1053/j.ajkd.2023.01.310

Ejemplares similares

COVID-19 Vaccination in Patients With Membranous Nephropathy
por: Visch, Ruben, et al.
Publicado: (2022)

Membranous nephropathy following anti–COVID-19 mRNA vaccination
por: Gueguen, Lorraine, et al.
Publicado: (2021)

A Case of Membranous Nephropathy Hypothesized to be Associated With COVID-19 Vaccine
por: Rashid, Wahida, et al.
Publicado: (2022)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

Mechanisms of Primary Membranous Nephropathy
por: Gu, Yan, et al.
Publicado: (2021)

Editorial: Primary membranous nephropathy
por: Infantino, Maria
Publicado: (2022)

Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination
por: Aydın, Mehmet Fethullah, et al.
Publicado: (2021)

COVID-19-Vaccine-Pfizer-BioNTech: Membranous nephropathy: case report
Publicado: (2021)

Choroidal Neovascularization in Primary Membranous Nephropathy
por: Gambato, Tommaso, et al.
Publicado: (2020)

308. Injectable Scaffold-based Vaccination For Prevention of Periprosthetic Joint Infection
por: Tatara, Alexander M, et al.
Publicado: (2023)

308. Do lung ultrasound abnormalities change during hospitalization for COVID-19?
por: Hwang, Jimin, et al.
Publicado: (2022)

Juvenile Membranous Nephropathy Developed after Human Papillomavirus (HPV) Vaccination
por: Arakawa, Haruna, et al.
Publicado: (2022)

Profile and primary treatment outcomes in membranous nephropathy
por: Hemanth Kumar, M.K., et al.
Publicado: (2022)

Membranous nephropathy in a patient with COVID-19 infection
por: Guo, Weiwen, et al.
Publicado: (2021)

Rituximab in Primary Membranous Nephropathy With Severe CKD
por: Naik, Sachin, et al.
Publicado: (2023)

Primary Membranous Glomerulonephritis-associated with Schistosomal Nephropathy
por: Mohammad Ibrahim, Walaa Hosny, et al.
Publicado: (2019)

IgA nephropathy after COVID-19 vaccination and analysis of reported cases
por: Mima, Akira, et al.
Publicado: (2023)

COVID-19 Vaccination in Immunoglobulin A Nephropathy
por: Lim, Cynthia Ciwei, et al.
Publicado: (2021)

Membranous Nephropathy in a Patient with Human Immunodeficiency Virus Shortly After Initiation of HAART with Atripla
por: Rawala, Muhammad Shabbir, et al.
Publicado: (2019)

P308: Elevated levels of CXCL16 in severe Covid-19 patients: effects on mortality
por: Smieszek, Sanda
Publicado: (2023)

Clinical Phenotypes and Predictors of Remission in Primary Membranous Nephropathy
por: Jurubiță, Roxana, et al.
Publicado: (2021)

Clinical implications of pathological features of primary membranous nephropathy
por: Zhang, Xiao-dan, et al.
Publicado: (2018)

Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy
por: Kronbichler, Andreas, et al.
Publicado: (2017)

New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination
por: Ma, Qiqi, et al.
Publicado: (2022)

Membranous nephropathy
por: Dantas, Márcio, et al.
Publicado: (2023)

POS-897 A CASE OF DE NOVO NELL-1 MEMBRANOUS NEPHROPATHY POST COVID-19 VACCINATION
por: GARG, A., et al.
Publicado: (2022)

The thickness of glomerular basement membrane predicts complete remission in primary membranous nephropathy
por: Duan, Suyan, et al.
Publicado: (2023)

Immune-Monitoring Disease Activity in Primary Membranous Nephropathy
por: Cravedi, Paolo, et al.
Publicado: (2019)

A cohort study of membranous nephropathy, primary or secondary
por: Arghiani, Maryam, et al.
Publicado: (2021)

Significance of thyroid dysfunction in the patients with primary membranous nephropathy
por: Gu, Qiu-hua, et al.
Publicado: (2022)

Membranous Nephropathy
por: Mathieson, Peter
Publicado: (1997)

Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination
por: Leong, Leanne Ca-Yin, et al.
Publicado: (2021)

A case of membranous nephropathy following Pfizer–BioNTech mRNA vaccination against COVID-19
por: Da, Yi, et al.
Publicado: (2021)

Complement activation products in the circulation and urine of primary membranous nephropathy
por: Zhang, Mu-fan, et al.
Publicado: (2019)

Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy
por: Zou, Honghong, et al.
Publicado: (2019)

Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy
por: Rojas-Rivera, Jorge, et al.
Publicado: (2021)

POS-901 GROSS HEMATURIA AFTER COVID-19 VACCINATION LED TO THE DIAGNOSIS OF IGA NEPHROPATHY
por: Kanamori, H.
Publicado: (2022)

MYB308-mediated transcriptional activation of plasma membrane H(+)-ATPase 6 promotes iron uptake in citrus
por: Fan, Zhengyan, et al.
Publicado: (2022)

308. Secondary Infections in Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 Pneumonia (PNA)
por: Rivosecchi, Ryan, et al.
Publicado: (2021)

A prospective randomized half-body study: 308 nm LED light vs. 308 nm excimer laser for localized psoriasis
por: Yu, Yingyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0cr60bt7jf3p9ocdt56h0ul2f1